» Articles » PMID: 32698347

PLGA Microspheres of HGH of Preserved Native State Prepared Using a Self-Regulated Process

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2020 Jul 24
PMID 32698347
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The challenges of formulating recombinant human growth hormone (rhGH) into sustained-release polymeric microspheres include two mutual causal factors, protein denaturing by the formulation process and severe initial burst release related with relative high dose. The stabilizers to protect the proteins must not evoke osmotic pressure inside the microspheres, and the contact of the protein with the interface between water and organic solution of the polymer must be minimized. To meet these criteria, rhGH was pre-formulated into polysaccharide particles via an aqueous-aqueous emulsion in the present study, followed by encapsulating the particles into microspheres through a self-regulated process to minimize the contact of the protein with the water-oil interface. Polysaccharides as the protein stabilizer did not evoke osmotic pressure as small sugar stabilizers, the cause of severe initial burst release. Reduced initial burst enabled reduced protein loading to 9% (from 22% of the once commercialized Nutropin depot), which in turn reduced the dosage form index from 80 to 8.7 and eased the initial burst. A series of physical chemical characterizations as well as biologic and pharmacokinetic assays confirmed that the present method is practically feasible for preparing microspheres of proteins.

Citing Articles

Patient-Centric Long-Acting Injectable and Implantable Platforms─An Industrial Perspective.

Alidori S, Subramanian R, Holm R Mol Pharm. 2024; 21(9):4238-4258.

PMID: 39160132 PMC: 11372838. DOI: 10.1021/acs.molpharmaceut.4c00665.


Actively separated microneedle patch for sustained-release of growth hormone to treat growth hormone deficiency.

Yang L, Liu Q, Wang X, Gao N, Li X, Chen H Acta Pharm Sin B. 2023; 13(1):344-358.

PMID: 36815043 PMC: 9939297. DOI: 10.1016/j.apsb.2022.04.015.


Recent Progress in Drug Release Testing Methods of Biopolymeric Particulate System.

Kim Y, Park E, Kim T, Na D Pharmaceutics. 2021; 13(8).

PMID: 34452274 PMC: 8399039. DOI: 10.3390/pharmaceutics13081313.


Exenatide Microspheres for Monthly Controlled-Release Aided by Magnesium Hydroxide.

Ge Y, Hu Z, Chen J, Qin Y, Wu F, Jin T Pharmaceutics. 2021; 13(6).

PMID: 34070856 PMC: 8226777. DOI: 10.3390/pharmaceutics13060816.


Protein Loading into Spongelike PLGA Microspheres.

Kim Y, Sah H Pharmaceutics. 2021; 13(2).

PMID: 33494293 PMC: 7909807. DOI: 10.3390/pharmaceutics13020137.

References
1.
Hoffman A, Biller B, Cook D, Baptista J, Silverman B, Dao L . Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiency. J Clin Endocrinol Metab. 2005; 90(12):6431-40. DOI: 10.1210/jc.2005-0928. View

2.
Reinhold S, Desai K, Zhang L, Olsen K, Schwendeman S . Self-healing microencapsulation of biomacromolecules without organic solvents. Angew Chem Int Ed Engl. 2012; 51(43):10800-3. PMC: 3817563. DOI: 10.1002/anie.201206387. View

3.
Lan L, Tian F, ZhuGe D, Zhuge Q, Shen B, Jin B . Implantable porous gelatin microspheres sustained release of bFGF and improved its neuroprotective effect on rats after spinal cord injury. PLoS One. 2017; 12(3):e0173814. PMC: 5349659. DOI: 10.1371/journal.pone.0173814. View

4.
Cleland J, Jones A . Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm Res. 1996; 13(10):1464-75. DOI: 10.1023/a:1016063109373. View

5.
Schwendeman S, Shah R, Bailey B, Schwendeman A . Injectable controlled release depots for large molecules. J Control Release. 2014; 190:240-53. PMC: 4261190. DOI: 10.1016/j.jconrel.2014.05.057. View